Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Packer

Showing results (181-190 of 4,797) with videos related to

Pageof 480
Sort By:
Journal of the American College of Cardiology|February 1, 1987
How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind menM Packer
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 23, 1997
Capitated care is unethicalS Packer
European Heart Journal|May 28, 2020
Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failureMilton Packer
Cardiovascular Diabetology|May 15, 2020
Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugsMilton Packer
Journal of the American College of Cardiology|June 26, 2024
Lessons for Cardiovascular Clinical Investigators: The Tumultuous 2,500-Year Journey of Physicians Who Ignited Our FireMilton Packer
European Journal of Heart Failure|October 25, 2023
Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?Milton Packer
Cardiovascular Diabetology|August 2, 2023
Lack of durable natriuresis and objective decongestion following SGLT2 inhibition in randomized controlled trials of patients with heart failureMilton Packer
European Journal of Heart Failure|July 12, 2023
Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heartMilton Packer
European Journal of Heart Failure|June 25, 2026
Does Phenotypic Heterogeneity in Heart Failure With Preserved Ejection Fraction Imply Mechanistic Heterogeneity? The Myth of a Phenotype-Directed Therapeutic Framework and the Mandate for a Falsifiable HypothesisMilton Packer
Journal of Cardiac Failure|October 25, 2002
The impossible task of developing a new treatment for heart failureMilton Packer
Pageof 480

Showing results (181-190 of 4,797) with videos related to

Sort By:
Pageof 480
Journal of the American College of Cardiology|February 1, 1987
How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind menM Packer
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 23, 1997
Capitated care is unethicalS Packer
European Heart Journal|May 28, 2020
Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failureMilton Packer
Cardiovascular Diabetology|May 15, 2020
Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugsMilton Packer
Journal of the American College of Cardiology|June 26, 2024
Lessons for Cardiovascular Clinical Investigators: The Tumultuous 2,500-Year Journey of Physicians Who Ignited Our FireMilton Packer
European Journal of Heart Failure|October 25, 2023
Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?Milton Packer
Cardiovascular Diabetology|August 2, 2023
Lack of durable natriuresis and objective decongestion following SGLT2 inhibition in randomized controlled trials of patients with heart failureMilton Packer
European Journal of Heart Failure|July 12, 2023
Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heartMilton Packer
European Journal of Heart Failure|June 25, 2026
Does Phenotypic Heterogeneity in Heart Failure With Preserved Ejection Fraction Imply Mechanistic Heterogeneity? The Myth of a Phenotype-Directed Therapeutic Framework and the Mandate for a Falsifiable HypothesisMilton Packer
Journal of Cardiac Failure|October 25, 2002
The impossible task of developing a new treatment for heart failureMilton Packer
Pageof 480